BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19881250)

  • 1. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.
    Lee S; Yabe D; Nohtomi K; Takada M; Morita R; Seino Y; Hirano T
    Endocr J; 2010; 57(2):119-26. PubMed ID: 19881250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of incretin on early-phase insulin secretion and glucose excursion.
    Shen J; Chen Z; Chen C; Zhu X; Han Y
    Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
    Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Yokoyama H; Haneda M
    Front Endocrinol (Lausanne); 2020; 11():214. PubMed ID: 32390941
    [No Abstract]   [Full Text] [Related]  

  • 7. Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients.
    Yabe D; Kuroe A; Watanabe K; Iwasaki M; Hamasaki A; Hamamoto Y; Harada N; Yamane S; Lee S; Murotani K; Deacon CF; Holst JJ; Hirano T; Inagaki N; Kurose T; Seino Y
    J Diabetes Complications; 2015 Apr; 29(3):413-21. PubMed ID: 25613093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of linagliptin on intact and total glucagon-like peptide-1 and gastric inhibitory polypeptide levels in insulin-dependent type 2 diabetes patients with and without moderate renal impairment.
    Meier JJ; Quast DR; Nauck MA; Schenker N; Deacon CF; Holst JJ; Plum-Mörschel L; Kapitza C
    Diabetes Obes Metab; 2022 May; 24(5):806-815. PubMed ID: 34984794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
    Oh TJ; Kim MY; Shin JY; Lee JC; Kim S; Park KS; Cho YM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):221-7. PubMed ID: 23405851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
    Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
    Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
    Mezza T; Moffa S; Ferraro PM; Quero G; Capece U; Carfì A; Cefalo CMA; Cinti F; Sorice GP; Impronta F; Mari A; Pontecorvi A; Alfieri S; Holst JJ; Giaccari A
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2685-2694. PubMed ID: 30874733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretins: their physiology and application in the treatment of diabetes mellitus.
    Tasyurek HM; Altunbas HA; Balci MK; Sanlioglu S
    Diabetes Metab Res Rev; 2014 Jul; 30(5):354-71. PubMed ID: 24989141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
    Matsumoto T; Harada N; Azuma M; Chihara Y; Murase K; Tachikawa R; Minami T; Hamada S; Tanizawa K; Inouchi M; Oga T; Mishima M; Chin K
    Ann Am Thorac Soc; 2016 Aug; 13(8):1378-87. PubMed ID: 27104640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.